TOPRA news

Hide

TOPRA announces new Board members for 2024

Posted on 27/10/2023
Results of the elections to the TOPRA Board of Directors were announced at the Annual Review Meeting held on 24 October at the TOPRA Symposium 2023 in Lisbon.

Recognising contribution in 2023

Posted on 27/10/2023
The 2023 recipients of formal recognition for their valued contributions to TOPRA and the regulatory affairs profession were announced at the Annual Review Meeting held on 24 October at the TOPRA Symposium 2023 in Lisbon.

AfriSummit

Posted on 11/09/2023
TOPRA has been confirmed as an Association Partner for the third AfriSummit, taking place on 8-11 October 2023 in Cairo, Egypt.

Changing of the guard at Regulatory Rapporteur

Posted on 17/05/2023
Editor-in-Chief of the Regulatory Rapporteur, Leslie Dowling, has stepped down from her role after 12 years at the helm of TOPRA’s respected international journal.

Digital badges

Posted on 14/04/2023
As part of our ongoing commitment to providing members with the tools to achieve their professional goals, we are introducing digital badges for TOPRA membership.

Mission to Mexico

Posted on 22/02/2023
The UK’s Department for International Trade recently coordinated a mission for Mexico’s healthcare regulatory agency COFEPRIS to meet British healthcare institutions. Learn more about TOPRA's involvement.

Regulatory Rapporteur moves fully online

Posted on 10/02/2023
With the wider world of scientific journal publishing moving online, the March 2023 marks the end of the Regulatory Rapporteur journal being produced in a hard copy format.

No content found

No content found

No content found

No content found

No content found

No content found

No content found

Consultations

Recently added consultations:

Human medicines
  • EMA: Guideline on registry-based studies
  • EMA: Guideline on SmPC for human normal immunoglobulin for intravenousadministration (IVIg)
  • EMA: Guideline on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIg) 

Visit our Consultations page for more about these and other active consultations.